Author Question: A mother brings in her 2-year-old daughter to be evaluated for blood in her urine. The mother brings ... (Read 183 times)

joblessjake · **on:** Jun 27, 2018

A mother brings in her 2-year-old daughter to be evaluated for blood in her urine. The mother brings in a urine specimen that appears to have blood in it.

When completing the admission assessment, the nurse notes that the patient was admitted as an observation patient two weeks ago with the same complaint, but all studies were negative. When the nurse questions the mother about the previous admission, the mother insists that her daughter's condition has remained unchanged. The nurse suspects which of the following disorders? 1. Urinary tract infection
2. Post-traumatic stress disorder
3. Munchausen syndrome by proxy
4. Schizoaffective disorder

Question 2

A 15-year-old girl has been diagnosed with Hepatitis B and will be starting treatment with Interferon-alpha (IFN). The nurse needs to educate the patient on this medication. Which of the following should be included in this education?

1. The medication reduces the replication of the Hepatitis B virus.
2. The patient needs to remain on treatment for one year.
3. Patients may develop resistance to Interferon-alpha over time.
4. Interferon-alpha has fewer side effects than Lamivudine, which is also used to treat Hepatitis B.

C.mcnichol98 · **Reply #1 on:** Jun 27, 2018

Answer to Question 1

3
Feedback
1. The child is not demonstrating signs of urinary tract infections.
2. The child does not demonstrate signs of post-traumatic stress disorder.
3. Munchausen syndrome by proxy is when a caregiver, usually the mother, attempts to make the child appear ill. The caregiver may put blood in the child's urine, stool, or vomit, or report fake symptoms to health-care providers. The child may be admitted to the hospital for diagnostic tests.
4. The child does not demonstrate psychiatric issues.

Answer to Question 2

1
Feedback
1. Interferon-alpha reduces the replication of the HBV virus. The medication is given as a subcutaneous injection three times a week for 4 to 6 months. Lamivudine, the other drug used to treat Hepatitis, has fewer side effects, but may patients develop a resistance.
2. The medication is given as a subcutaneous injection three times a week for 4 to 6 months.
3. Lamivudine, the other drug used to treat Hepatitis, has fewer side effects, but may patients develop a resistance.
4. Lamivudine, the other drug used to treat Hepatitis, has fewer side effects, but may patients develop a resistance.